Tabrecta 200 mg film-coated tablets
Sponsors
Oslo University Hospital HF, Institut National De La Sante Et De La Recherche Medicale, Universita' Degli Studi Di Torino
Conditions
CancerNon Small Cell Lung CancerUnresectable locally advanced and/or metastatic soft-tissue sarcoma
Phase 2
Improving public cancer care by implementing precision medicine in Norway
A multi-cohort phase 2 treatment clinical study investigating efficacy of approved drugs outside indication in patients with advanced cancer. IMPRESS-Norway
RecruitingCTIS2023-507894-16-00
Start: 2021-04-01Target: 6000Updated: 2026-01-22
DYNAMIC ” IDentifY the best therapeutic sequeNcing strAtegy in oncogene addICted NSCLC:”
“A multi-arms prospective, randomized phase II study to evaluate the best sequential
therapeutic strategis in patients with metastatic non-small cell lung cancer harboring
targetable genomic driver alterations”
Not yet recruitingCTIS2026-525268-16-00
Target: 962Updated: 2026-10-19